Raghu Kolluri
@RKolluriMD
Followers
1K
Following
4K
Media
369
Statuses
3K
System Med Dir - Vasc Med & Vasc Ultrasound @OhioHealth; Clin Prof of Med @Ohiou; Past-President @SVM_tweets; @VIVAPhysicians
Columbus, OH
Joined February 2014
#VIVA25 is excited to introduce The InnoSphere! Join bold, future-forward sessions in Devices & AI - exploring how cutting-edge tech and intelligent systems are transforming care. See the agenda: https://t.co/ykrchllrJK
0
1
2
Whether you're a seasoned expert or rising clinician, #VIVA25 and #TheVEINS25 are your spaces to: -Learn -Collaborate -Innovate Register today: https://t.co/uTFYCQEhgd Take advantage of combined registration savings available to Physicians, PAs/NPs, Nurses, Techs, & other HCPs
0
3
8
New opportunity for early career physicians (U.S., up to 5 years post-training)! The #VIVA25 Early Career Leadership Program offers mentorship, leadership development & networking opportunities. Applications close July 10! Learn more and apply: https://t.co/8jLwo4lLcs
0
1
2
Why attend #VIVA25 and #TheVEINS25? - 350+ Presentations - 150+ Expert Faculty - Innovation Summits - Hands-On Learning - Live Cases - And more! View the agenda here: https://t.co/ykrchllZzi
0
3
10
Every year, VIVA and The VEINS feature groundbreaking and clinically significant data presentations. This year, we are sharing a late-breaking clinical trial presentation from our 2024 conferences each week. See this week's featured presentation here:
Late-breaking data presented at #TheVEINS24 by Dr. Julie Bulman: Clot Burden Reduction With a Novel Thrombectomy Device for the Treatment of Acute Pulmonary Embolism: RV/LV ratio and MMS Reductions Observed in the Pilot ENGULF Trial https://t.co/qj5tuZ1Wjy
0
2
4
Chronic venous insufficiency is mainly due to venous hypertension, the cause of which can be structural or functional. Treatment is aimed at decreasing venous hypertension through conservative, nonprocedural management. Full Clinical Practice article: https://t.co/Y8bo3MEaND
4
127
452
Congratulations @EriFukayaMD and @RKolluriMD !
So proud of my good friend and colleague, Eri Fukaya, for publishing this definitive article on venous disease in the NEJM today. Eri is a tour de force and world leader on the topic. Coupled with her recent promotion to full Professor, it’s been a great year for Eri! Bravo!
1
8
15
So proud of my good friend and colleague, Eri Fukaya, for publishing this definitive article on venous disease in the NEJM today. Eri is a tour de force and world leader on the topic. Coupled with her recent promotion to full Professor, it’s been a great year for Eri! Bravo!
New in the December 19/26, 2024, issue of NEJM: Ponsegromab for Cancer Cachexia (phase 1B study) https://t.co/xu1i252fK8 Levofloxacin and Multidrug-Resistant Tuberculosis (VQUIN MDR trial) https://t.co/nNs2xN7Ubk
3
14
44
Welcome on board Kush! @VIVAPhysicians is incredibly lucky. 👏🏽 @kush_r_desai
The VIVA Foundation is pleased to announce the appointment of Dr. Kush R. Desai to The VIVA Foundation Board of Directors. We are excited to have his expertise, passion, and leadership join us. Congratulations, Dr. @kush_r_desai!
1
2
14
Congratulations to our top-scoring Face-Off presenters! Ishmael Raheem, MD Ana Paula Morales Allende, MD Victor Rivera, MD All 3 will give their winning presentations in the Spotlight Theater.
1
6
14
Coming up at #TheVEINS24: @KathleenGibson6 will be presented the 2024 VEINS award by @RKolluriMD in recognition of her significant contributions to improving the care of patients with venous disease.
0
4
24
#TheVEINS24 has begun! Thank you to our Co-Course Directors @MaureenKohi @RKolluriMD @paragpatel_IR, Scientific Committee, faculty, and all our attendees who make this conference possible.
0
8
23
Next month, 150+ of the best & brightest minds from all specialties in vascular disease will come together to give their perspectives on what’s happening now & what’s next for clinicians. Don't miss the data, cases, tech, & hands-on labs. Register now - https://t.co/uTFYCQEP5L
0
7
6
Missed last week's webinar? The recording of VIVA’s most recent webinar is now available. Watch here: https://t.co/8jLwo4lLcs
0
8
9
We are saddened by the loss of Dr. Nick Hopkins, an educator, collaborator, innovator, and dear friend. His contribution to multidisciplinary treatment of patients will serve as a model for decades to come.
0
4
10
Attending #VIVA24? Election Day falls during VIVA this year, see https://t.co/ferRijVi8D for more information/voting instructions.
0
1
3
NEXT WEEK Free CME Webinar Tuesday, 10/1 | 8pm ET Bridging the NIVL Evidence Gap: A Conversation With Authors of the VIVA/AVF/AVLS Consensus Statement Register here: https://t.co/T720mzpPI4
0
7
10
Today is the day 🙌 #Readyfortakeoff Come on down to kickoff #SVM #VSS2024👏 @evratchford @adityasharmamd @AaronAdayMD @stanhenkin @DKadiandodov @RKolluriMD @herbaronowMD @heatherlgornik @EstherSHKimMD @JoshuaBeckmanMD @DrMarkCreager @EriFukayaMD @JayBishopMD #Vascular
0
4
12
Upcoming Webinar Bridging the NIVL Evidence Gap: A Conversation With Authors of the VIVA/AVF/AVLS Consensus Statement Tuesday, October 1 8pm ET Register here: https://t.co/T720mzpPI4
0
9
12
Join us on Tuesday, October 1, to hear directly from a selection of these authors as they take a closer look at the statements and offer additional insights on the paper’s methodology. Register for this free webinar now:
The VIVA Foundation is pleased to announce the publication of a multidisciplinary set of consensus statements in conjunction with @myAVLS and @VenousForum regarding the diagnosis and treatment of nonthrombotic iliac vein lesions (NIVL). Read here: https://t.co/384HZfBcZD
0
2
5